LyondellBasell Industries NV (LYB)

Investment Committee Summary

Investment Thesis

At $65.20 on 25 August 2026, on roughly 8 times forward earnings and a dividend yield only distressed cyclicals carry, the market prices LyondellBasell as a deep cyclical stuck near trough, discounting little recovery in petrochemical spreads. The engine concurs on the character and goes further on the price. Triangulated fair value of $41.72 is a gap of -36% to spot and the shares are trading rich to that anchor; the probability-weighted expected value of $58.37 sits far closer to the quote than the triangulation does, which is what leaves the rating at SELL rather than lower, alongside a twelve-month target of $55.51. Cross-sectional peers in coatings and specialty chemicals trade at multiples this business will never earn, confirming a commodity rather than a compounder. The base case rests on mid-cycle spreads returning the group operating margin toward the level near 11% on roughly flat volumes, while structural overcapacity carries the single heaviest weight in the tree. The discounted-cash-flow anchor warns that the payout is not fully covered by mid-cycle free cash flow against net debt of ~$11.6B. The single most damaging risk is that new Middle Eastern and Chinese ethylene capacity keeps operating rates and spreads below mid-cycle for years rather than quarters.

Narrative drafted 2026-08-16 by claude-opus-5 under supervision; reviewed by Marinus 2026-08-16.

The dashboard below is the whole argument on one page: spot ($65.20) against each valuation anchor, the scenario tree, technicals and the options-implied move.

Anti-Thesis (The Real Bear Case)

The steelman bear is structural, not cyclical. A wave of new integrated ethylene and polyolefin capacity from the Middle East and China arrives into flat-to-declining developed-market demand, so global operating rates never recover to the levels mid-cycle economics assume. Spreads settle on a permanently lower plateau, the group operating margin sits well below the level near 11% the base case requires, and operating cash flow fails to cover the dividend and the capital programme together. Management defends the payout with balance-sheet capacity against net debt of ~$11.6B, leverage drifts upward, and the equity de-rates toward the structural target below the 52-week low. The yield does not protect the holder in that path; it is the first thing to be cut, and the cut confirms the de-rating rather than causing it. Earnings and the multiple compress together, and the new capacity does not go away.

Key Debate

Gross Margin explains 51% of Monte Carlo outcome variance — the single variable that decides which side is right.

What the Market Is Pricing In

At the current price, the market pays 7.1× consensus forward EPS, vs the house DCF terminal 6.0×, and a peer median 22.8×. The house DCF sits 60% below spot, so the market is pricing in more than the house case — roughly 3.1pp of revenue CAGR.

Variant perception: the house view is below-consensus, and the thesis is primarily event-driven.

Scenario Analysis

The scenario tree spans a structural 'Structural — Petrochem Overcapacity / Demand Peak' downside ($14.70) to a 'Spike — Supply Dislocation' bull case ($137); the probability-weighted blend (PWEV $58.37) is -10% versus spot.

Share-count charge: none applied. The probability-weighted value above is the gross per-share figure — no annual dilution is deducted — stock-based compensation runs at 0.3% of revenue; free cash flow net of SBC is $0.29B. SBC is therefore disclosed, not charged: read the per-share figures as before dilution.

Scenario rationale — the driver path behind every target:

• Structural — Petrochem Overcapacity / Demand Peak (24%, $14.70). Structural impairment — capacity glut / demand peak: earnings AND the multiple compress together. Target sits below the 52-week low by construction.
• Downturn — Trough Margins (18%, $30.60). Cyclical downturn — product price − feedstock cost + utilisation + industrial demand weakens for 1–2 years before normalising.
• Base — Mid-Cycle Spreads (32%, $60.30). Mid-cycle — normalised product price − feedstock cost + utilisation + industrial demand; disciplined capital allocation; steady returns.
• Upcycle — Tight Spreads (18%, $106). Upside — supply dislocation / tight spreads lifts earnings above mid-cycle; the multiple expands modestly.
• Spike — Supply Dislocation (8%, $137). Upside tail — sustained tight conditions or a structural re-rate on supply dislocation / tight spreads.

Valuation Triangulation

Three weighted anchors — an intrinsic dcf, a scenario-weighted pwev and a monte carlo median (student-t + regime switching) — read them with their basis in mind. The Monte Carlo, the DCF terminal and any peer re-rate key off a market multiple, so they are not fully independent; only discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat three numbers as three independent votes.

The house blend DECLARES five anchor weights — DCF 35%, scenario PWEV 25%, Monte Carlo 15%, sum-of-parts 15%, peer re-rate 10%. For this name sum-of-parts, peer P/E re-rate are not computed, so 25% of the declared weight is redistributed across the anchors that exist — which is why the weights above differ from the declared ones. The fair value is unaffected by this disclosure; the blend has always worked this way.

Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.

Monte Carlo — the outcome distribution

10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $49.94 and 34% of paths finish above spot. The variance decomposition shows the gross margin is the dominant swing factor (51% of variance). The fundamental driver, not the multiple, sets the spread — a cleaner setup.

DCF — the cash-flow anchor

Independent of the market multiple: a 5-year path, WACC 9.5%, 6.0x terminal FCF multiple → $26.31. This anchor is deliberately the heaviest (47%): it is the valuation least hostage to the current multiple regime.

Peer benchmarking — relative value

Against the peer cohort, re-rating to the peer-median EV/Revenue multiple implies $256; the peer-median forward P/E is 22.8x, but the engine carries no P/E-implied price for this name (no forward-EPS basis at the peer step). A premium is only justified by superior growth/margins; otherwise it is multiple risk. Excluded from the weighted blend — shown only as a market cross-check.

Across all anchors the spread is 393% of the median — wide (genuine disagreement — the blend carries low valuation confidence).

Sensitivity

DCF/share — WACC × terminal multiple

DCF/share — revenue CAGR Δ × op-margin Δ

Tornado — DCF/share swing by driver (widest first)

Company lever — SoP/share vs Commodity & Diversified Chemicals multiple (AI re-rating) (base 7.0x)

Peer Quality & Weighting

Quality-weighted forward P/E: 23.6× (simple median 22.8×). Direct peers count 100%, segment 50%, broad 25%.

Valuation-anchor screen: DCF (exit) (low-confidence cross-check (>50% below median)). Anchor median 54.2. Extreme/excluded anchors carry no headline weight.

Historical-range cross-check: 52-week range $39.52–$83.07, centre $57.30 (-12% vs spot); spot sits at the 59th percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.

Risk / Reward & Margin of Safety

That ratio compares triangulated upside against the probability-weighted bear target, not the extreme tail; with a leg missing it is withheld rather than computed from a magnitude. Bull case (Spike — Supply Dislocation): $137.

Company Overview & Business Model

LyondellBasell Industries NV — BASIC MATERIALS · SPECIALTY CHEMICALS. LyondellBasell Industries N.V. (NYSE: LYB) is a Dutch-domiciled multinational chemical company with American and British roots, incorporated in the Netherlands, with U.S. operations headquarters in Houston, Texas, and offices in London, UK. The company is the largest licensor of polyethylene and polypropylene technologies.

How it makes money.

Edge. Narrow moat — LyondellBasell's moat is cost-advantaged US/Gulf-Coast feedstock (ethane) and scale plus proprietary licensing (Oleflex/polyolefin technology), which supports only a mid-single-digit-to-high-single-digit terminal multiple appropriate for a deep cyclical. FALSIFIABLE: if global ethylene/PE overcapacity keeps spreads at trough through the next cycle, the cost advantage is being competed away and even a ~7x multiple is too generous - fair value sits below the current dividend-supported floor.

Revenue-Segment Breakdown

The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)

Named Exposures

Demand & pricing cycle (FACT/ESTIMATE)

Capital intensity & shareholder returns (ESTIMATE)

Structural risk vs optionality (INFERENCE)

Balance Sheet & Liquidity

Balance-sheet data as of 2025-12-31 (Alpha Vantage).

Capital Allocation

Free-Cash-Flow Quality

Accounting quality: SBC 1% of revenue.

Competitive Moat

Moat sources:

• US Gulf-Coast ethane feedstock cost advantage vs naphtha crackers
• Scale in olefins/polyolefins and integrated cracker footprint
• Technology licensing (Oleflex, polyolefin process IP) - annuity-like royalty
• NO pricing power - commodity chemicals are spread-takers, not price-setters

Earnings-Call Disconfirmation & Sentiment

Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.

Management vs analyst tone (2026Q2): management +0.59 vs analyst floor +0.00 → delta +0.59 (n=31 mgmt / 10 Q&A; 85th pctile across the S&P book, z +1.1).

Flag: ELEVATED — management unusually upbeat vs the analyst floor relative to peers (disconfirmation watch).

News (last 365d, 733 articles): avg ticker sentiment -0.06 (bullish 7% / bearish 29%)

Consensus & Market Expectations

_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.

Catalyst Calendar

• 2026-10-30 (~67d) — European asset-rationalization / portfolio-review decision (authored)
• 2027-02-15 (~175d) — Dividend-sustainability review at FY results (authored)

Forecast Track Record

• EPS surprise: beat 50% of the last 8 quarters; average surprise -15.3%.
• Prior-forecast backtest (11 snapshots, 2026-06-26→2026-08-20): directional hit-rate 18%; mean predicted -5.6% vs realised +10.8%. Disconfirming track record is reported, not suppressed.

Catalyst Timeline

5 catalysts in the next 90 days (of 14 tracked). Importance 1–3; confidence 0–1.

_Sources: extended.catalysts, data/catalysts/.json, data/catalysts/macro.json, AV DIVIDENDS, opex 3rd-Friday calc.

Regulatory & Legal Risk

Probabilities and sensitivities are analyst estimates, not market-implied.

Scenario Macro & Key Risks

Scenario-macro rows withheld pending re-authoring: 1 carrying another cluster's vocabulary or a frozen figure — recorded in the narrative quarantine ledger.

Decision Rules (Machine-Checked)

Stance: Hold — 0 bullish / 1 bearish / 0 caution rules triggered of 5 evaluable (1 lacked data).

Machine-checked rules over disclosed inputs. The authored falsification triggers elsewhere in this report are analyst judgment and are NOT evaluated here. The stance is a portfolio-management signal and does not modify the published research rating.

Reasons the Thesis Could Fail (Falsifiable)

Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:

• Integrated ethylene / polyethylene chain margin (US Gulf, cents/lb) below trough-consistent level for 2 consecutive quarters (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)
• Group EBITDA margin below 9.8% (midpoint of Base 11.4% and Downturn 8.2% op-margin proxy) (2 consecutive prints). A sustained margin print between Base and Downturn confirms the cycle is rolling toward the higher-probability bear case rather than normalising.
• Operating cash flow coverage of dividend + capex below 1.0x (OCF < dividend $1.76B + capex ~$1.9B) (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)
• Net debt / EBITDA above 3.5x (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)
• Global operating-rate for ethylene / polyolefins below the level consistent with structural overcapacity absorption stalling (2 consecutive prints). New Middle East and Chinese capacity keeps operating rates depressed; a stall confirms the Structural demand-peak thesis rather than a normal cyclical trough.

Fact / Inference / Speculation

• FACT: Spot $65.20; 52-week range $39.52–$83.07; engine rating SELL; house target $55.51 (-15%). (source: Alpha Vantage 2026-08-24, 25 August 2026)
• INFERENCE: Triangulated FV $41.72 (-36% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core; the cash-flow anchor sits below the multiple-discipline core.
• SPECULATION: At current prices the embedded bet is that Gross Margin keeps surprising favourably — an operating call the next two prints will test.

Conviction Score

Research Conviction measures the strength and quality of the research setup — input coverage, financial quality, valuation support, process agreement. It is NOT the probability that the recommendation succeeds; the forecast track record section is the evidence on that.

40.7/100 (confidence band 26.8–54.5), 3rd percentile of 858 covered names (as of 2026-08-24). Weighted composite under config ros-1.19.0 — every component and its inputs below.

Missing inputs (macro tailwinds) are excluded and the remaining weights renormalised; the confidence band widens accordingly.

Score history: 41.1 → 41.1 → 44.3 → 40.8 → 40.8 → 40.0 → 40.3 → 40.3.

Probability-Weighted Return Profile

Horizon: 1 year — at this horizon CAGR equals total return by definition. Expected values are the probability-weighted sums over the full scenario set below.

The gross expected return is the probability-weighted scenario return (it reconciles to the gross PWEV); the diluted figure applies the SBC share-count charge and matches the published PWEV-based target.

Expected Alpha

Expected return minus the return this name is REQUIRED to deliver for its risk (1-year horizon). Constants are pre-registered (preregistered-static (amendment #2, 2026-07-29); not fitted to MCH outcomes).

A negative expected alpha does not change the rating — it says the expected return does not clear the risk-adjusted hurdle at today's price. Rating mechanics are unchanged by this section.

Probability Cross-Checks

Not authoritative. The scenario probabilities in this report are AUTHORED — a judgement about how the world might go, not a measurement. Nothing below modifies them, the target, the rating or any position size. These checks ask only whether anything outside our own model agrees with us; where it does not, that is information for the reader, not a correction we have quietly applied.

Authored set: 5 scenarios, probabilities summing to 1.0, mean target $58.37.

Factor Exposures

Cross-sectional percentiles over 858 covered names (style scores sector-demeaned; thematic = return-beta to the theme's proxy ETF). 50 = estate median.

Market interaction: correlation vs SPY +0.30, vs QQQ +0.21 (trailing ~1y daily returns).

Options Intelligence

Preferred structure: Collar. The selector reads the equity view (direction) and the volatility surface — nothing here re-prices the chain.

• bearish with rich premium — finance downside protection by selling an expensive call (collar)
• Direction bearish from the overlay conviction/rating (read-only input).
• IV/RV at the 85th percentile of the cross-section → high vol bucket. This is the measure that selects the structure above: it ranks how rich this name's implied vol is against its own realised vol, relative to other names.
• Reported alongside and not used to select: this name's own ATM IV sits at the 58th percentile of its own month-end history (decile 6). The two measures disagree here — vol is high for this name by its own history while its options are not unusually rich against its realised vol. Where they diverge, the cross-sectional measure is the one acting.
• IV term structure is in contango (longer-dated richer, slope +3.9pp) — favour longer-dated ownership (LEAPS) or calendars that are long the cheaper front.

IV term structure (contango, slope +3.9pp): 25-DTE 40% · 116-DTE 42% · 389-DTE 44%

Economics copied verbatim from the options overlay (priced from the listed chain (EOD marks)); the selector does not re-price.

Alternatives: Protective Put. IV rank shown via the name's own monthly IV history (advisory); structure selected on the cross-sectional IV/RV percentile. Model output for research and education only — not individualised investment advice. Position-sizing and stance figures are mechanical outputs of the disclosed rules and inputs; they do not consider any person's objectives, financial situation, or tax status.

Position Sizing Framework

research rating is SELL-tier — the model carries no long position.

Model output for research and education only — not individualised investment advice. Position-sizing and stance figures are mechanical outputs of the disclosed rules and inputs; they do not consider any person's objectives, financial situation, or tax status.

Options Overlay

A defined-risk way to express the SELL equity view. Chain as of 2026-08-24 — end-of-day marks — indicative, not executable quotes.

Market signals — ATM IV 40.5% (elevated regime) · expected move ±8.4% (2026-09-18) · put/call OI 1.81 · ATM Δ 0.54 / Θ -0.06 / ν 0.07. Direction: NEUTRAL (implied return -36.0% to triangulated fair value $41.72).

Covered Call (if held) (Income / neutral) — Short 70 C · 2026-09-18 · premium $1.02 · yield 1.6% · priced from the listed chain (EOD marks)

Converts a near-fair holding into income by agreeing to sell at a higher strike — worth weighing when upside looks limited near fair value and being called away is acceptable. Elevated implied volatility currently enriches the premium collected. Illustrative — no outcome is implied or guaranteed.

Put Spread (income) (Income / would-own) — Short 60 P / Long 55 P · 2026-10-16 · net $0.88 · net entry $59.12 · yield 1.5% · RoR 21.0% · max loss $4.12 · priced from the listed chain (EOD marks)

Gets paid to wait for a lower entry, with the tail capped: the sold put collects premium while the cheaper long wing below it caps the maximum loss at the spread width — a defined-risk alternative to a naked cash-secured put.

Protective Collar (if held) (Hedge) — Long 57.5 P / Short 72.5 C · 2027-03-19 · net $1.5 · floor -12.0% · cap +11.0% · priced from the listed chain (EOD marks)

For a holder who wants to stay invested but cap risk: the sold call funds most of the protective put, fencing the position into a band — a way to ride out a de-rating without selling.

Indicative options structures — a defined-risk expression of the equity view, model-and-market illustrated from the last-close chain. NOT personalised advice or an executable quote; premiums, IV and greeks move intraday. Options carry the risk of total loss of premium. Not a registered financial adviser.

Rating Bridge

Rating = SELL because:

• Probability-weighted scenario value implies -10% vs spot
• Monte Carlo median implies -23% vs spot
• DCF fair value implies -60% vs spot — but this is terminal-value sensitive (exit-multiple $26.31 vs Gordon $71.44, 172% apart), so it carries less weight
• Bear case (Structural — Petrochem Overcapacity / Demand Peak) downside is -77% vs spot
• Net: the valuation anchor itself sits 36.0% below spot, so there is no reward leg to weigh against the bear case and the reward-to-risk ratio is withheld rather than computed off a negative upside. The rating warrants a Sell.

Model Appendix

DCF — line items

FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 7% of revenue, weighted from the segments) — not a single conversion fudge.

WACC 9.5% · Σ PV(FCF) $10B + PV(terminal) $10B = EV $20B; − net debt $11.6B → equity $9B ÷ diluted shares $0.33B = $26.31/share (exit-multiple terminal).

• Gordon terminal at 2.5% → $71.44/share — a genuinely non-multiple, cash-based cross-check; the exit-multiple and Gordon values bracket the terminal-value risk.
• Incremental ROIC on the forecast capex ≈ 3% vs WACC 9.5% → below WACC — the incremental build is value-dilutive.

Peer set

Implied prices at the peer medians: EV/Rev → $256 (no P/E-implied price — no forward-EPS basis at the peer step).

Weighted fair-value math

Assumption Register

Sensitivity-ranked drivers (widest fair-value swing first): Op margin ±3pp (34.0); Revenue CAGR ±3pp (15.0); Capex intensity ±15% (14.0); Terminal × ±15% (9.0); WACC ±1pp (4.0).

Inputs, Sources & Confidence

Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)

Research Provenance

Load-Bearing Assumptions

DCF: WACC 9.5%, terminal multiple 6×, FY+5 revenue $32B. Triangulation leans 47% on DCF, 33% on PWEV, 20% on the Monte Carlo median.